Co-Founder / Acting Chair, Board of Directors James A. Stewart, EdD
BOARD OF DIRECTORS
Ekokobe Fonkem, DO, Neurologist/Neuro-Oncologist
Chief of Neuro-Oncology
Joan and William Shapiro Endowed Chair in Brain Tumors Barrow Neurological Institute
Maniza Aziz Johnson, PhD
Professor of Civil and Electrical Engineering Technology (Retired) Portland Community College Meningioma Brain Tumor Survivor MBTN Inc - Mentor Portland, Oregon
Tomi M Leeper, CPA
US Department of Health and Human Services Centers for Medicare and Medicaid Baltimore, Maryland
Romney M Phillips, JD, ESQ
Phillips Law Office
Shenell A Tolson, DrPH
Environmental Scientist/Regulatory Action Leader,
US Environmental Protection Agency Washington, District of Columbia
Edward L Williams, MSW-LICSW
Director of Family Services, (Retired) Riverside State Psychiatric Hospital
Ricardo D Wrice, MBA
CEO and Editor-in-Chief The Leadership Blend Media Company Atlanta, Georgia
MEET THE FOUNDER
JO-ANNE EVANS COLEMAN, PhD, EdD, CNP
Jo-Anne 'EC' Evans Coleman PhD, EdD, CNP, Founder, Meningioma Brain Tumor Network, Inc (MBTN), a 501c3 nonprofit organization, is a seven (7) year survivor of a Right-Wing Spheno-orbital Meningioma (with cavernous sinus involvement) brain tumor. The establishment of MBTN harbors on Dr. EC’s vision for the usage of interprofessional collaborative services, that directly address the numerous diminished quality of life psycho-social aspects of living with/surviving a brain tumor, that are encountered by meningioma patients, survivors, and the effects on caregivers, and families.
Founder, Dr. EC, is superiorly qualified to lead this organization. She has over 30 years of leadership, administrative and management experience, working within institutions of higher education, entrepreneurship in both non-profit and private sectors, as a healthcare practitioner, and as an independent contractor for various business, industry, and government agencies. In 2015, nine (9) months post her craniotomy and cranioplasty, she became a Minnesota State Advocacy Leader for the National Brain Tumor Society, where she annually testifies on Capitol Hill for congressional funding that continuously supports brain tumor treatment and research.
Highlighting her interests in advocacy is the drive garnered from her challenges when she was afflicted with a Grade 1 spheno-orbital meningioma and is now a brain tumor pioneering staunch voice for the "lived experienced" survivor. Through her work at MBTN, she is building a platform for improved pre and post-operative assessments, treatments, and services to better determine meningioma brain tumor patients quality of life outcomes.